This figure illustrates the mean expected clearance rates and confidence bounds around the estimates. Estimates of expected IH clearance are expressed as percent clearance relative to initial condition for each treatment, along with associated posterior interquartile range (thick lines) and 95% credible interval (thin lines). The expected efficacy of control arms was estimated to be 6 percent (95% BCI: 1% to 11%), i.e., we would expect to see, on average, 6 percent clearance of IH in children who receive placebo or no treatment during the study period. All non-control treatments were estimated to have a larger expected clearance than control. The largest mean estimate of clearance was for oral propranolol (95%, 95% BCI: 88% to 99%).

Figure 5Estimates of expected IH clearance

Note: Estimates of expected IH clearance are expressed as percent clearance relative to initial condition for each treatment, along with associated posterior interquartile range (thick lines) and 95% credible interval (thin lines).

From: Results

Cover of Diagnosis and Management of Infantile Hemangioma
Diagnosis and Management of Infantile Hemangioma [Internet].
Comparative Effectiveness Reviews, No. 168.
Chinnadurai S, Snyder K, Sathe N, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.